1. Shulskaya, Marina V, Semenova, Ekaterina I, Rudenok, Margarita M, Shadrina, Maria I, Alieva, Anelya Kh. 2024. Analysis of LRRN3, MEF2C, SLC22A, and P2RY12 Gene Expression in the Peripheral Blood of Patients in the Early Stages of Parkinson's Disease. In Biomedicines, 12, . doi:10.3390/biomedicines12071391. https://pubmed.ncbi.nlm.nih.gov/39061965/
2. Guo, Xing, Hu, Wenjun, Gao, Zijie, Wu, Qianqian, Li, Weiguo. 2023. Identification of PLOD3 and LRRN3 as potential biomarkers for Parkinson's disease based on integrative analysis. In NPJ Parkinson's disease, 9, 82. doi:10.1038/s41531-023-00527-8. https://pubmed.ncbi.nlm.nih.gov/37258507/
3. Baiju, Nikita, Sandanger, Torkjel M, Sætrom, Pål, Nøst, Therese H. 2021. Gene expression in blood reflects smoking exposure among cancer-free women in the Norwegian Women and Cancer (NOWAC) postgenome cohort. In Scientific reports, 11, 680. doi:10.1038/s41598-020-80158-8. https://pubmed.ncbi.nlm.nih.gov/33436844/
4. Jiang, Fenghua, Wu, Qianqian, Sun, Shuqian, Bi, Guanghui, Guo, Ling. 2019. Identification of potential diagnostic biomarkers for Parkinson's disease. In FEBS open bio, 9, 1460-1468. doi:10.1002/2211-5463.12687. https://pubmed.ncbi.nlm.nih.gov/31199560/
5. Maas, Silvana C E, Mens, Michelle M J, Kühnel, Brigitte, Kayser, Manfred, Ghanbari, Mohsen. 2020. Smoking-related changes in DNA methylation and gene expression are associated with cardio-metabolic traits. In Clinical epigenetics, 12, 157. doi:10.1186/s13148-020-00951-0. https://pubmed.ncbi.nlm.nih.gov/33092652/
智鼠故事 
